Michigan Initial Experience Using Tigertriever for Thrombectomy

Recruiting now

Conditions studied: Blood Clot, Thrombectomy, Ischemic Stroke

In brief

The purpose of this research study is to collect data about the effectiveness (i.e. how the device works) and safety (how safe it is to use such a device) of the Tigertriever in restoring blood flow by removing thrombus (or blood clot) from a large intracranial vessel (blood vessel in the brain) in patients experiencing ischemic stroke within 8 hours of symptom onset.

Key facts

Study ID

NCT07363525

Run by

Henry Ford Health System

People needed

150

Starts

2026-01-15

Expected to finish

2028-12-31

Last updated by the study team

2026-05-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients admitted with large vessel occlusion (LVO) and treated with the Tigertriever, as per the approved indication.
• Tigertriever was used as the first line treatment in the target vessel.
• A signed informed consent.
• Age ≥ 18.

You may not qualify if…

• 1. Evidence of acute brain hemorrhage on NCCT or MR at admission. 2. Prior hemorrhage, stroke, thrombolysis, and/or endovascular therapy in the last 3 months.
• pre-stroke disability (pre-stroke mRS ≥ 2).

Where it is running

• Henry Ford Hospital — Detroit, Michigan, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.